In this issue:
Classification of the TME
BEMPEG phase III trial
PET-CT underestimates the extent of LN disease
Risk of further progression of death among durable progression
EOL decisions in ICI-treated patients
Determinants of OS in patients with MUM
Contribution of MEK inhibition to BRAFi
Loss of Y chromosome in uveal melanoma
Predictors of sentinel LN metastasis in thin invasive melanomas
Acral melanoma inhibitory pathways
Please login below to download this issue (PDF)